Acrivon Therapeutics, Inc. (ACRV)

1.83 +0.13 (+7.65%) USD  |  NASDAQ  |  Jan 14, 16:00
1.82 -0.01 (-0.55%) After-Hours: 20:00
More

Acrivon Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for ACRV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Aclarion, Inc. Upgrade
Vistagen Therapeutics, Inc. Upgrade
Spero Therapeutics, Inc. Upgrade
Humacyte, Inc. Upgrade
PMGC Holdings, Inc. Upgrade